Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.  

The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.

Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.

“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”


Read more: 

 Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Go Back

Share this story

Comments


Related articles


Global update

Parkinson’s campaigners cycle across Germany

The bike tour raising awareness of Parkinson’s disease

READ MORE
Paul Mayhew-Archer at The Comedy Store

Interviews

Paul Mayhew-Archer: “laughing at my Parkinson’s”

We spoke to comic legend Paul Mayhew-Archer about his condition

READ MORE
Sofiya Lysenko holding her science awards.

Interviews

Meet the 17-year-old inventor “treating Parkinson’s from the root”

Student creates a DNA nanorobot for more targeted Parkinson’s treatment

READ MORE